Donor Lung Sequence Number and Survival after Lung Transplantation in the United States.

RATIONALE: In the United States, an algorithm known as the 'match-run' creates an ordered ranking of potential recipients for available lung allografts. A recipient's match-run position, or 'sequence number,' is available to the transplant center when contacted with a lung offer. Lung offers with higher sequence numbers may be interpreted as a crowd-sourced evaluation of poor organ quality, though the association between the sequence number at which a lung is accepted and its recipient's post-transplant outcomes is unclear.

OBJECTIVES: We sought to evaluate the primary reasons provided when a lung offer was refused by a transplant center, transplant center and donor/organ factors associated with a higher sequence number at acceptance, and the association of the sequence number at acceptance with post-transplant mortality and graft failure.

METHODS: Match-run outcomes for lung offers that occurred in the United States from May 2007 through June 2014 were merged with recipient follow-up data through December 2017. Associations between the sequence number at the time of acceptance with selected transplant center and donor characteristics were estimated using multivariable logistic and multinomial regression models. The associations between the final sequence number and recipient survival and graft survival were estimated using multivariable time-to-event models.

RESULTS: Of 10,981 lung offer acceptances, nearly 70% were accepted by the top 10 ranked recipients. Higher median annual center volume and potential indicators of organ quality (e.g., abnormal chest radiograph or bronchoscopy) were associated with a higher sequence number at acceptance. There was weak evidence for a small positive relationship between the sequence number at acceptance and both mortality and graft failure. For example, the unadjusted and adjusted hazard ratios for death associated with the log-sequence number at acceptance were 1.019 (95% CI: 1.001 to 1.038) and 1.011 (0.989 to 1.033), respectively. On the absolute scale, using the multivariable model, a 10-fold increase in the sequence number translated into a 0.8% absolute decline in the predicted 5-year survival.

CONCLUSION: Acceptance of a donor lung offer at a later point in the match-run was associated with measurable indicators of organ quality but not with clinically meaningful differences in post-transplant mortality or graft failure.